Guidance Notes for Newsletter Contributors11 May 2025 The ILTS newsletter has been published since 2014, twice monthly until October 2018 by the Texas-based firm Multiview, then monthly since November by ILTS headquarters staff in Berlin. Its purpose is to update members and others with a professional interest in liver transplantation on ILTS activities, upcoming meetings, and recent scientific papers. A data protection-compliant circulation of >10,000 recipients has been built, and the newsletter has recently been integrated with ILTS social media initiatives. MailChimp software is used in its design, layout, distribution, analytics and archiving. This guide describes the structure, content and general approach to the newsletter developed over the few years and recently re-invigorated by the new in-house production team. We hope that its circulation and value to readers will grow further with fresh input from our headquarters staff and new contributors. Regular Content
All the above sections except WHAT WE’RE READING are drafted by ILTS staff. Designated Vanguard Committee members select scientific content for WHAT WE’RE READING. Current contributors are:
Contributors please note:Latest Pubmed abstracts can be retrieved by free subscriptions to the search engine Pubcrawler (http://pubcrawler.gen.tcd.ie, search term ‘Liver Transplantation’), National Library of Medicine (NCBI) alerts, and designated journal eTOCs. Select the three best articles in your specialty. You can submit fewer or more than three if you judge that quality and value to readers justify this. Selected papers should be clinical, not focused on basic science unless exceptionally important. Reviews are acceptable if they are regarded as important and have a useful abstract (or are Open Access), and as long as there are no original papers of greater interest in the preceding month. Unless the article is designated Open Access, or is published in an Open Access journal (e.g. Transplant Direct, PLoS One), the newsletter can only use the Pubmed abstract. Publishing full text in the newsletter without permission breaches copyright. The format for selected abstracts should be as follows, submitted as a Word document:
If the article is from the ILTS official journal Transplantation, ‘(FREE TO ILTS MEMBERS)’ should appear after the journal title. If the article is available Open Access ‘(FREE FULL TEXT)’ should appear after the journal title.
Submit full abstract but highlight first 1-3 sentences in yellow to designate text that should appear on newsletter front page, giving an idea of abstract content. The rest of the abstract will be set up to appear under a READ MORE… link. Commentary on your selected abstracts is welcome and will be attributed to you as ‘Read commentary by YOUR NAME…’. The text will not appear on the front page, but under a dedicated link. Please format and submit your commentary as follows:
Try to keep your commentary short (under 250 words) to make it more readable, effective and sustainable. Try not to simply re-write the abstract – consider any of the following approaches:
ILTS staff will aim to circulate a complete newsletter draft to all editors before publication. Please check that your abstract links and commentaries load on all your devices and notify ILTS staff if any problems. Ordering of abstractsThe editors will tend to feature abstracts from the official ILTS journal Transplantation at or near the top of the listing, although papers in other journals can supersede these if especially important or newsworthy. Abstracts on related topics will be grouped together. When your selection and commentaries are done, send it to John Klinck and Andrea Olmos. submission deadlines for abstract selections and commentaries are as follows:
Newsletter submission day: Analysis has shown that newsletters sent out on Tuesdays, Wednesdays and Thursdays have better open-click ratios. Readers tend to give lower priority to this type of email on Mondays and Fridays. Newsletter developmentOpening rates will be monitored. Variations in format and distribution timing will be trialled to optimise value for both readers and sponsors. Contributors will be consulted if any trial proposes to alter or omit any part of their content. |